4-(pyridin-3-ylmethylene)-2-(3,4,5-trimethoxyphenyl)oxazol-5(4H)-one

ID: ALA1091767

PubChem CID: 6083135

Max Phase: Preclinical

Molecular Formula: C18H16N2O5

Molecular Weight: 340.34

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1cc(C2=N/C(=C\c3cccnc3)C(=O)O2)cc(OC)c1OC

Standard InChI:  InChI=1S/C18H16N2O5/c1-22-14-8-12(9-15(23-2)16(14)24-3)17-20-13(18(21)25-17)7-11-5-4-6-19-10-11/h4-10H,1-3H3/b13-7-

Standard InChI Key:  CZYRBEYGZLMHBI-QPEQYQDCSA-N

Molfile:  

     RDKit          2D

 25 27  0  0  0  0  0  0  0  0999 V2000
    0.2251   -5.7919    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1904   -6.6185    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8879   -7.0600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6205   -6.6760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6513   -5.8460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9531   -5.4083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9840   -4.5838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7134   -4.1984    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3852   -4.6839    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0509   -4.1918    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7899   -3.4118    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.9649   -3.4170    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4771   -2.7517    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8721   -4.1972    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2782   -4.9166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1024   -4.9237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5215   -4.2121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1104   -3.4919    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2875   -3.4883    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5083   -5.6417    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.3333   -5.6488    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3452   -4.2177    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.7625   -3.5060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5307   -2.7782    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.1214   -2.0618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 12 13  2  0
  1  2  2  0
  6  7  1  0
 14 15  2  0
  3  4  2  0
 15 16  1  0
  7  8  2  0
 16 17  2  0
  8  9  1  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 10 14  1  0
  4  5  1  0
  2  3  1  0
 20 21  1  0
 16 20  1  0
  5  6  2  0
  9 10  2  0
 22 23  1  0
 17 22  1  0
 10 11  1  0
 11 12  1  0
 24 25  1  0
 18 24  1  0
 12  8  1  0
  6  1  1  0
M  END

Associated Targets(Human)

DAPK3 Tchem Death-associated protein kinase 3 (2108 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 340.34Molecular Weight (Monoisotopic): 340.1059AlogP: 2.45#Rotatable Bonds: 5
Polar Surface Area: 79.24Molecular Species: NEUTRALHBA: 7HBD:
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 4.68CX LogP: 2.15CX LogD: 2.15
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.61Np Likeness Score: -0.81

References

1. Okamoto M, Takayama K, Shimizu T, Muroya A, Furuya T..  (2010)  Structure-activity relationship of novel DAPK inhibitors identified by structure-based virtual screening.,  18  (7): [PMID:20206532] [10.1016/j.bmc.2010.02.018]

Source